Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1529022

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1529022

Nasal Packing Devices Market, By Product (Injectables, Gels, Sprays, Dressings), Type (Bioresorbable, Non-absorbable), End-use (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings) - Global Forecast 2024 - 2032

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global Nasal Packing Devices Market will record a 5.2% CAGR from 2024 to 2032 due to advancements in device technology and the rising incidence of nasal disorders. Technological innovations enhance the safety, comfort, and efficacy of nasal packing solutions, addressing evolving patient needs and preferences. Also, increasing cases of nasal conditions, such as sinusitis and post-surgical care requirements, fuel demand for advanced nasal packing devices. This combination of cutting-edge technology and a growing patient base ensures continued market expansion and the development of more effective nasal treatment solutions.

For instance, in July 2023, Aptar Pharma introduced its first metal-free nasal spray pump, APF Futurity, designed for delivering nasal saline and similar OTC formulations. This innovation aims to enhance safety and comfort in nasal treatments. This innovation reflects a growing trend toward eliminating metal components to reduce potential allergic reactions and enhance user comfort. By focusing on metal-free design, Aptar Pharma addresses safety and patient experience concerns, potentially setting a new standard in the market and prompting competitors to adopt similar advancements.

The nasal packing devices industry is classified based on product, type, end-use, and region.

The sprays segment will experience marked growth through 2032, attributed to its ease of use, patient comfort, and effectiveness. These devices provide rapid relief and are less invasive than traditional nasal packing methods. Sprays are preferred by both healthcare providers and patients for their ability to deliver medication directly to the affected area, reducing complications and promoting faster healing. The increasing prevalence of nasal disorders and advancements in spray technology further drive this segment's dominance.

The home care settings segment will witness a substantial uptick between 2024 and 2032, propelled by the growing trend towards self-managed healthcare and the increasing prevalence of nasal conditions treated at home. Patients and caregivers are seeking user-friendly, effective nasal packing solutions that can be easily administered outside clinical settings. The convenience of home care devices, coupled with advancements in product design that enhance usability and comfort, is driving this segment's growth, reflecting a shift towards more personalized and accessible care options.

Asia Pacific nasal packing devices market will demonstrate a decent CAGR during 2024 and 2032, spurred by the nation's rapidly expanding healthcare infrastructure, increasing awareness about nasal health, and rising prevalence of respiratory conditions. The region's large and diverse population, along with growing investments in healthcare technology and improvements in medical facilities, supports the demand for advanced nasal packing solutions. Additionally, the increasing adoption of home-based care and rising disposable incomes contribute to market growth, making the Asia Pacific a key contributor to the nasal packing devices industry.

Product Code: 9472

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of nasal disorders
      • 3.2.1.2 Rising number of nasal surgeries
      • 3.2.1.3 Growing aging population base
      • 3.2.1.4 Significant technological advancements
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of alternatives
      • 3.2.2.2 Side effects associated with nasal packing devices
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Injectables
  • 5.3 Gels
  • 5.4 Sprays
  • 5.5 Dressings

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Bioresorbable
  • 6.3 Non-absorbable

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Ambulatory surgical centers
  • 7.5 Home care settings
  • 7.6 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
    • 8.3.7 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Aegis Lifesciences
  • 9.2 Boston Medical Products Inc.
  • 9.3 Cook
  • 9.4 FABCO
  • 9.5 Fannin Limited
  • 9.6 INNOVIA MEDICAL
  • 9.7 Lohmann & Rauscher GmbH & Co. KG
  • 9.8 Medtronic plc
  • 9.9 Meril Life Sciences Pvt. Ltd.
  • 9.10 Network Medical Products Ltd.
  • 9.11 Olympus Corporation
  • 9.12 Smith & Nephew plc
  • 9.13 Stryker Corporation
  • 9.14 Summit Medical LLC.
  • 9.15 Teleflex Incorporated
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!